1.Findling, RL, Gracious, BL, McNamara, NK, et al.Rapid, continuous cycling and psychiatric co-morbidity In pediatric bipolar I disorder. Bipolar Disord. 2001;3:202–210.
2.West, SA, McElroy, SL, Strakowski, SM, Keck, PE Jr, McConvllle, BJ. Attention deficit hyperactivity disorder in adolescent mania. Am J Psychiatry. 1995;152:271–273.
3.Winokur, G, Coryell, W, Keller, M, Endicott, J, Leon, A. A family study of manic-depressive (bipolar I) disease. Arch Gen Psychiatry. 1995;52:367–373.
4.Tamam, L, Karakus, G, Ozpoyraz, N. Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: prevalence and clinical correlates. Eur Arch Psychiatry Clin Neurosci. 2008;258:385–393.
5.Wingo, AP, Ghaemi, SN. A systematic review of rates and diagnostic validity of comorbld adult attention deficit/hyperactivity disorder and bipolar disorder. J Clin Psychiatry. 2007;68:1776–1784.
6.Sachs, GS, Baldassano, CF, Truman, CJ, Guille, C. Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder. Am J Psychiatry. 2000; 157:466–468.
7.Rucklidge, JJ. Impact of ADHD on the neurocognitlve functioning of adolescents with Bipolar Disorder. Biol Psychiatry. 2006;60:921–928.
8.Henin, A, Mick, E, Biederman, J, et al.Can bipolar disorder-specific neuropsychological Impairments In children be identified? J Consult Clin Psychol. 2007;75:210–220.
9.State, RC, Frye, MA, Altshuler, LL, et al.Chart review of the impact of Attention-Deficit/ Hyperactivity Disorder comorbidity on response to lithium or Divalproex Sodium in adolescent mania. J Clin Psychiatry. 2004;65:1057–1063.
10.Consoli, AI, Bouzamondo, A, Guile, J-M, Lechat, P, Cohen, D. Comorbidity with ADHD decreases response to pharmacotherapy in children and adolescents with acute mania: Evidence from a meta-analysis. Can J Psychiatry. 2007;52:323–328.
11.Biederman, J, Hammerness, P, Doyle, R, Joshl, G, Aleardi, M, Mick, E. Risperidone treatment for ADHD in children and adolescents with bipolar disorder. Neuropsychiatr Dis Treat. 2008;4:203–207.
12.Tramontina, S, Zeni, CP, Pheula, GF, de Souza, CK, Rohde, LA. Ariplprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial. CNS Spectr. 2007;12:758–762.
13.Singh, J, Zarate, C. Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials. Bipolar Disord. 2006;8:696–709.
14.Waxmonsky, J. Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness. Curr Opin Pediatr. 2003;15:476–482.
15.Wozniak, J. Recognizing and Managing Bipolar Disorder In Children. J Clin Psychiatry. 2005;66:18–23.
16.Ghaemi, SN, Hsu, DJ, Rosenquist, KJ, Pardo, TB, Goodwin, FK. Extrapyramidal side effects with atypical neuroleptics In bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:209–213.
17.Blader, JC, Kafantaris, V. Pharmacological treatment of bipolar disorder among children and adolescents. Expert Rev Neurother. 2007;7:259–270.
18.Baumgaertel, A. Alternative and controversial treatments for attention-deficit/hyper-activity disorder. Pediatr Clin North Am. 1999;46:977–992.
19.Kaplan, BJ, Crawford, SG, Field, CJ, Simpson, JS. Vitamins, minerals, and mood. Psychol Bull. 2007;133:747–760.
20.Kaplan, BJ, Simpson, JSA, Ferre, RC, Gorman, CP, McMullen, DM, Crawford, SG. Effective mood stabilization with a chelated mineral supplement: An open-label trial In bipolar disorder. J Clin Psychiatry. 2001;62:936–944.
21.Popper, CW. Do vitamins or minerals (apart from lithium) have mood-stabilising effects? J Clin Psychiatry. 2001;62:933–935.
22.Simmons, M. Nutritional approach to bipolar disorder. J Clin Psychiatry. 2003;64:338.
23.Kaplan, BJ, Crawford, SG, Gardner, B, Farrelly, G. Treatment of mood lability and explosive, rage with minerals and vitamins: two case studies in children. J Child Adolesc Psychopharmacol.2002:12:205–219.
24.Kaplan, BJ, Fisher, JE, Crawford, SG, Field, CJ, Kolb, B. Improved mood and behavior during treatment with a mineral-vitamin supplement: an open-label case series of children. J Child Adolesc Psychopharmacol. 2004;14:115–122.
25.Rucklidge, JJ. Successful treatment of OCD with a micronutrient supplement following partial response to Cognitive Behavioral Therapy (CBT): A case study. J Anxiety Disord. 2009;23:836–840.
26.Frazier, E, Fristad, MA, Arnold, LE. Multinutrient supplement as treatment: Literature review and case report of a 12-year-old boy with bipolar disorder. J Child Adolesc Psychopharmacol. 2009;19:453–460.
27.Gately, D, Kaplan, BJ. Database analysis of adults with bipolar disorder consuming a multinutrient formula. Clin Med Psychiatry. 2009;4:3–16.
28.RuckJidge, JJ, Taylor, M, Whitehead, K. Effect of mlcronutrients on behavior and mood in adults with ADHD: Evidence from an 8-week open label trial with natural extension. J Atten Disord. In press.
29.Spearing, MK, Post, RM, Leverich, GS, Brandt, D, Nolen, W. Modification of the Clinical Global Impressions (CGI) scale for use with bipolar illness (BP): the CGI: BP. Psychiatry Res. 1997;73:159–171.
30.Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, 4th ed, Text revision. Washington, DC: American Psychiatric Association; 2000.
31.Young, RC, Biggs, JT, Ziegler, VE, Meyer, DA. A rating scale for mania: Reliability, validity, and sensitivity. Br J Psychiatry. 1978;133:429–435.
32.Montgomery, SA, Asberg, M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389.
33.Umphress, VJ, Lambert, MJ, Smart, DW, Barlow, SH, Clouse, G. Concurrent and construct validity of the outcome questionnaire. J Psychoeducational Assess. 1997;15:40–55.
34.Conners, CK, Erhardt, D, Sparrow, MA. Conners' Adult ADHD Rating Scales (CAARS). Arch Clin Neuropsychol. 2003;18:431–437.
35.Wechsler, D.Manual for the WAIS-III. New York, NY: Psychological Corporation; 1997.
36.Adams, W, Sheslow, D. Wide Range Assessment of Memory and Learning Administration Manual - II. Wilmington, DE: Jastak; 2003.
37.Wilkinson, GS. WRAT3 Administration Manual. Delaware: Wide Range; 1993.
38.Connors, CK. Connors Continuous Performance Test II: Technical Guide. Toronto, Canada: Multi-Health Systems; 2000.
39.First, MB, Spitzer, RL, Gibbon, M, Williams, JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. New York, NY: Biometrics Research, New York State Psychiatric Institute; 2002.
40.Epstein, J, Johnson, D, Conners, C. Conners' Adult ADHD Diagnostic Interview for DSM-IVTM(CAADID): Technical Manual. New York, NY: MHS; 2002.
41.Rucklidge, JJ, Tannock, R. Neuropsychological profiles of adolescents with ADHD: Effects of reading difficulties and gender. J Child Psychol Psychiatry. 2002;43:988–1003.
42.Douglas, VI. Cognitive control processes in attention deficit hyperactivity disorder. In: Quay, HC, Hogan, AE, eds. Handbook of Disruptive Disorders. New York, NY: Plenum Press; 1999:105–138.
43.Kuntsi, J, Oosterlaan, J, Stevenson, J. Psychological mechanisms in hyperactivity: I Response inhibition deficit, working memory impairment, delay aversion, or something else? J Child Psychol Psychiatry. 2001;42:199–201.
44.McGee, RA, Clark, SE, Symons, DK. Does the Conners' Continuous Performance Test aid in ADHD diagnosis? J Abnorm Child Psychol. 2000;28:415–424.
45.Epstein, JN, Conners, CK, Hervey, AS, et al.Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry. 2006;47:446–456.
46.Quraishl, S; Frangou, S. Neuropsychology of bipolar disorder: A review. J Affect Disord. 2002;72:209–226.
47.Savitz, JB, van der Merwe, L, Stein, DJ, Solms, M, Ramesar, RS. Neuropsychological task performance in bipolar spectrum illness: genetics, alcohol abuse, medication, and childhood trauma. Bipolar Disord. 2008;10:479–494.
48.Arnold, LE, Bozzolo, H, Hollway, J, et al.Serum zinc correlates with parent- and teacher-rated inattention In children with Attentlon-Deficit/Hyperactlvity Disorder. J Child Adolesc Psychopharmacol. 2005;15:628–636.
49.Starobrat-Hermelin, B. The effect of deficiency of selected bioelements on hyperactivity in children with certain specified mental disorders. Ann Acad Med Stetin. 1998;44:297–314.
50.Saavedra, JM. Probiotics plus antibiotics: Regulating our bacterial environment, J Pediatr. 1999;135:535–537.
51.Wynnea, AG, McCartneya, AL, Brostoffb, J, Hudspithb, BN, Gibsona, GR. An in vitro assessment of the effects of broad-spectrum antibiotics on the human gut microflora and concomitant isolation of a Lactobacillus plantarum with anti-Candida activities. Anaerobe. 2004;10:165–169.
52.Levy, J. The effects of antibiotic use on gastrointestinal function. Am J Gastroenterol. 2000;95:S8–S10.
53.Young, LT. Is bipolar disorder a mitochondrial disease? J Psychiatry Neurosci. 2007;32:160–161.
54.Russell, VA, Oades, RD, Tannock, R, et al.Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis. Behav Brain Funct 2006;2:30.
55.Gardner, A, Boles, RG. Is a “Mitochondrial Psychiatry” in the future? A review. Cur Psychiatry Rev. 2005;1:255–271.
56.Parikh, S, Saneto, R, Falk, MJ, Anselm, I, Cohen, BH, Haas, R. A modern approach to the treatment of mitochondrial disease. Pediatr Neurol. 2009;41:414–430.
57.Mehl-Madrona, L, Leung, B, Kennedy, C, Paul, S, Kaplan, BJ. A naturalistic case-control study of micronutrients versus standard medication management In autism. J Child Adolesc Psychopharmacol. In press.